Evidence Weighed for Suicide/Self-Harm With Obesity Drugs at Salimpour Site.

Dr. Salimpour Site |Following reports that the European Medicines Agency (EMA) is looking into instances of suicide or self-harm after patients took the weight loss drugs semaglutide or liraglutide, the manufacturer, Novo Nordisk, issued a statement to Medscape in which it says it "remains

Medscape

Evidence Weighed for Suicide/Self-Harm With Obesity Drugs

Evidence Weighed for Suicide/Self-Harm With Obesity Drugs

Following reports that the European Medicines Agency (EMA) is looking into instances of suicide or self-harm after patients took the weight loss drugs semaglutide or liraglutide, the manufacturer, Novo Nordisk, issued a statement to Medscape in which it says it "remains confident in the benefit risk profile of the products and remains committed to ensuring patient safety."